| Year |
Citation |
Score |
| 2020 |
Paul MR, Pan TC, Pant DK, Shih NN, Chen Y, Harvey KL, Solomon A, Lieberman D, Morrissette JJ, Soucier-Ernst D, Goodman NG, Stavropoulos SW, Maxwell KN, Clark C, Belka GK, ... Feldman M, et al. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets. The Journal of Clinical Investigation. PMID 32657779 DOI: 10.1172/Jci129941 |
0.328 |
|
| 2020 |
Yan C, Nakane K, Wang X, Fu Y, Lu H, Fan X, Feldman MD, Madabhushi A, Xu J. Automated gleason grading on prostate biopsy slides by statistical representations of homology profile. Computer Methods and Programs in Biomedicine. 194: 105528. PMID 32470903 DOI: 10.1016/J.Cmpb.2020.105528 |
0.3 |
|
| 2020 |
Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal P, Madabhushi A. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139401 DOI: 10.1158/1078-0432.Ccr-19-2659 |
0.335 |
|
| 2020 |
Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, Velu P, Rajiah P, Alilou M, Choi H, Feldman MD, Gilkeson RC, Linden P, Fu P, Pass H, et al. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study. Lung Cancer (Amsterdam, Netherlands). 142: 90-97. PMID 32120229 DOI: 10.1016/J.Lungcan.2020.02.018 |
0.304 |
|
| 2019 |
McDonald ES, Doot RK, Young AJ, Schubert EK, Pryma DA, Farwell MD, Tchou J, Nayak A, Ziober A, Feldman MD, DeMichele A, Clark AS, Shah PD, Lee H, Carlin SD, et al. Breast Cancer F-ISO-1 Uptake as a Marker of Proliferation Status. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31836680 DOI: 10.2967/Jnumed.119.232363 |
0.326 |
|
| 2019 |
Chitalia R, Rowland J, McDonald ES, Pantalone L, Cohen EA, Gastounioti A, Feldman M, Schnall M, Conant E, Kontos D. Imaging phenotypes of breast cancer heterogeneity in pre-operative breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) scans predict 10-year recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31732521 DOI: 10.1158/1078-0432.Ccr-18-4067 |
0.325 |
|
| 2019 |
Khorrami M, Prasanna P, Gupta A, Patil P, Velu PD, Thawani R, Corredor G, Alilou M, Bera K, Fu P, Feldman M, Velcheti V, Madabhushi A. Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non-small cell lung cancer. Cancer Immunology Research. PMID 31719058 DOI: 10.1158/2326-6066.Cir-19-0476 |
0.325 |
|
| 2019 |
Kraya AA, Maxwell KN, Wubbenhorst B, Wenz BM, Pluta J, Rech AJ, Dorfman LM, Lunceford N, Barrett A, Mitra N, Morrissette JJ, Feldman M, Nayak A, Domchek SM, Vonderheide RH, et al. Genomic signatures predict the immunogenicity of BRCA-deficient breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30914433 DOI: 10.1158/1078-0432.Ccr-18-0468 |
0.32 |
|
| 2019 |
Banerjee S, Alwine JC, Wei Z, Tian T, Shih N, Sperling C, Guzzo T, Feldman MD, Robertson ES. Microbiome signatures in prostate cancer. Carcinogenesis. PMID 30794288 DOI: 10.1093/Carcin/Bgz008 |
0.312 |
|
| 2019 |
Thompson JC, Fan R, Black T, Yu GH, Savitch SL, Chien A, Yee SS, Sen M, Hwang WT, Katz SI, Feldman M, Vachani A, Carpenter EL. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer (Amsterdam, Netherlands). 127: 25-33. PMID 30642547 DOI: 10.1016/J.Lungcan.2018.11.020 |
0.303 |
|
| 2019 |
Clark AS, McAndrew NP, Troxel A, Feldman M, Lal P, Rosen M, Burrell J, Redlinger C, Gallgher M, Bradbury AR, Domchek SM, Fox KR, O'Dwyer PJ, DeMichele AM. Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30635336 DOI: 10.1158/1078-0432.Ccr-18-0790 |
0.314 |
|
| 2019 |
Leo P, Janowczyk A, Elliott R, Janaki N, Shiradkar R, Farrè X, Yamoah K, Rebbeck T, Shih N, Khani F, Robinson BD, Eklund L, Ettala O, Taimen P, Bostrom P, ... Feldman MD, et al. Computerized histomorphometric features of glandular architecture predict risk of biochemical recurrence following radical prostatectomy: A multisite study. Journal of Clinical Oncology. 37: 5060-5060. DOI: 10.1200/Jco.2019.37.15_Suppl.5060 |
0.313 |
|
| 2019 |
Wang X, Barrera C, Bera K, Lu C, Feldman M, Schalper K, Rimm D, Velcheti V, Madabhushi A. MA25.02 Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 14: S350-S351. DOI: 10.1016/J.Jtho.2019.08.710 |
0.322 |
|
| 2018 |
Milman T, Iacob C, Lauer S, Feldman MD, Zhang PJL. Adenocarcinoma, Not Otherwise Specified, Arising in Accessory Lacrimal Gland: A Diagnostic Challenge. Ocular Oncology and Pathology. 4: 67-72. PMID 30320083 DOI: 10.1159/000478730 |
0.355 |
|
| 2018 |
Leo P, Elliott R, Shih NNC, Gupta S, Feldman M, Madabhushi A. Stable and discriminating features are predictive of cancer presence and Gleason grade in radical prostatectomy specimens: a multi-site study. Scientific Reports. 8: 14918. PMID 30297720 DOI: 10.1038/S41598-018-33026-5 |
0.316 |
|
| 2018 |
Martei YM, Narasimhamurthy M, Prabhakar P, Hutson J, Setlhako DI, Chiyapo S, Ramogola-Masire D, Makozhombwe I, Feldman M, Kayembe MKA, Grover S. Breast Cancer Pathology Turnaround Time in Botswana. Journal of Global Oncology. 1-7. PMID 30241141 DOI: 10.1200/Jgo.17.00090 |
0.304 |
|
| 2018 |
Penzias G, Singanamalli A, Elliott R, Gollamudi J, Shih N, Feldman M, Stricker PD, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Fu P, Tiwari P, Viswanath S, et al. Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings. Plos One. 13: e0200730. PMID 30169514 DOI: 10.1371/Journal.Pone.0200730 |
0.327 |
|
| 2018 |
Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Peck KN, DeMichele AM, Alwine JC, Robertson ES. Distinct Microbial Signatures Associated With Different Breast Cancer Types. Frontiers in Microbiology. 9: 951. PMID 29867857 DOI: 10.3389/Fmicb.2018.00951 |
0.324 |
|
| 2018 |
Whitney J, Corredor G, Janowczyk A, Ganesan S, Doyle S, Tomaszewski J, Feldman M, Gilmore H, Madabhushi A. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer. Bmc Cancer. 18: 610. PMID 29848291 DOI: 10.1186/S12885-018-4448-9 |
0.301 |
|
| 2018 |
Cruz-Roa A, Gilmore H, Basavanhally A, Feldman M, Ganesan S, Shih N, Tomaszewski J, Madabhushi A, González F. High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection. Plos One. 13: e0196828. PMID 29795581 DOI: 10.1371/Journal.Pone.0196828 |
0.327 |
|
| 2018 |
Garg R, Blando JM, Perez CJ, Lal P, Feldman MD, Smyth EM, Ricciotti E, Grosser T, Benavides F, Kazanietz MG. COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer. Oncogene. PMID 29765153 DOI: 10.1038/S41388-018-0318-9 |
0.305 |
|
| 2018 |
Nirschl JJ, Janowczyk A, Peyster EG, Frank R, Margulies KB, Feldman MD, Madabhushi A. A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue. Plos One. 13: e0192726. PMID 29614076 DOI: 10.1371/Journal.Pone.0192726 |
0.716 |
|
| 2018 |
Guha M, Srinivasan S, Raman P, Jiang Y, Kaufman BA, Taylor D, Dong D, Chakrabarti R, Picard M, Carstens RP, Kijima Y, Feldman M, Avadhani NG. Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects. Biochimica Et Biophysica Acta. PMID 29309924 DOI: 10.1016/J.Bbadis.2018.01.002 |
0.341 |
|
| 2018 |
Verma N, Harding D, Mohammadi A, Goldstein LJ, Gilmore HL, Feldman MD, Tomaszewski J, Basavanhally A, Lloyd M, Fu P, Ganesan S, Davidson NE, Madabhushi A, Monaco J. Image-based risk score to predict recurrence of ER+ breast cancer in ECOG-ACRIN Cancer Research Group E2197. Journal of Clinical Oncology. 36: 540-540. DOI: 10.1200/Jco.2018.36.15_Suppl.540 |
0.359 |
|
| 2018 |
Kraya AA, Maxwell KN, Wubbenhorst B, Wenz BM, Pluta J, Rech AJ, Lunceford N, Barrett A, Mitra N, Morrissette JJD, Nayak A, Feldman M, Domchek SM, Vonderheide RH, Nathanson KL. Abstract A22: Homologous recombination deficiency negatively predicts for immune infiltration and antitumor immune activity in breast tumors with BRCA1/2 alterations Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A22 |
0.337 |
|
| 2018 |
Paul, Pan T, Pant D, Belka G, Chen Y, Shih N, Lieberman D, Morrissette J, Soucier-Ernst D, Clark C, Stavropoulos W, Maxwell K, Feldman M, DeMichele A, Chodosh L. Abstract PD8-04: Evolutionary history and genomic landscape of metastatic breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd8-04 |
0.371 |
|
| 2018 |
Chitalia R, Rowland J, McDonald E, Pantalone L, Cohen E, Gastounioti A, Thomas K, Batiste R, Feldman M, Schnall, Conant E, Kontos D. Abstract PD2-10: Radiomic phenotypes of tumor heterogeneity from pre-operative DCE-MRI independently predict breast cancer recurrence after 10-year follow-up from primary invasive diagnosis Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd2-10 |
0.385 |
|
| 2018 |
Whitney J, Romeo-Bucheli D, Janowczyk A, Ganesan S, Feldman M, Gilmore H, Madabhushi A. Abstract P4-09-11: Computer extracted features of tumor grade from H&E images predict oncotype DX risk categories for early stage ER+ breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-09-11 |
0.359 |
|
| 2018 |
DeMichele A, Soucier-Ernst D, Clark C, Shih N, Stavropoulos W, Maxwell K, Feldman M, Lierbamen D, Morrissette J, Paul, Pan T, Wang J, Belka G, Chen Y, Yee S, et al. Abstract OT2-06-03: METAMORPH: METAstatic markers of recurrent tumor PHenotype for breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Ot2-06-03 |
0.39 |
|
| 2018 |
Yee D, DeMichele A, Isaacs C, Symmans F, Yau C, Albain K, Hylton N, Forero-Torres A, Veer Lv, Perlmutter J, Rugo H, Melisko M, Chen Y, Balassanian R, Krings G, ... ... Feldman M, et al. Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Gs3-08 |
0.31 |
|
| 2018 |
Leo P, Gawlik A, Zhu G, Feldman M, Gupta S, Veltri R, Madabhushi A. MP35-02 COMPUTER-EXTRACTED FEATURES OF NUCLEAR AND GLANDULAR MORPHOLOGY FROM DIGITAL H&E TISSUE IMAGES PREDICT PROSTATE CANCER BIOCHEMICAL RECURRENCE AND METASTASIS FOLLOWING RADICAL PROSTATECTOMY Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1115 |
0.315 |
|
| 2017 |
Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, ... ... Feldman M, et al. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nature Communications. 8: 319. PMID 28831036 DOI: 10.1038/S41467-017-00388-9 |
0.324 |
|
| 2017 |
Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, et al. Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Research and Treatment. PMID 28653249 DOI: 10.1007/S10549-017-4339-9 |
0.354 |
|
| 2017 |
Ruella M, Klichinsky M, Kenderian SS, Shestova O, Ziober A, Kraft DO, Feldman M, Wasik MA, June CH, Gill S. Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells. Cancer Discovery. PMID 28576927 DOI: 10.1182/Blood.V128.22.43.43 |
0.326 |
|
| 2017 |
Cruz-Roa A, Gilmore H, Basavanhally A, Feldman M, Ganesan S, Shih NNC, Tomaszewski J, González FA, Madabhushi A. Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent. Scientific Reports. 7: 46450. PMID 28418027 DOI: 10.1038/Srep46450 |
0.379 |
|
| 2017 |
Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Coukos G, Alwine JC, Robertson ES. The ovarian cancer oncobiome. Oncotarget. PMID 28410234 DOI: 10.18632/Oncotarget.16717 |
0.325 |
|
| 2017 |
Gawlik A, Lee G, Feldman MD, Zhu G, Veltri RW, Madabhushi A. Computer extracted nuclear features from tumor and benign regions of Feulgen and H&E images to help predict recurrence in prostate cancer patients following radical prostatectomy. Journal of Clinical Oncology. 35: e16556-e16556. DOI: 10.1200/Jco.2017.35.15_Suppl.E16556 |
0.354 |
|
| 2017 |
Kraya A, Maxwell KN, Wenz BM, Wubbenhorst B, Sloover DD, Lunceford N, Barrett A, Morrissette JD, Feldman M, Vonderheide RH, Domcheck SM, Nathanson KL. Abstract A12: Analysis of tumor immunogenicity in germline BRCA1/2 mutation associated breast and ovarian cancers Cancer Immunology Research. 5. DOI: 10.1158/2326-6074.Tumimm16-A12 |
0.322 |
|
| 2017 |
Thompson JC, Savitch SL, Fan R, Yee SS, Powers CA, Yu G, Gebrian L, Rao C, Gross S, Feldman M, Vachani A, Carpenter EL. Abstract 3736: Characterization of tumor cells and assessment of PD-L1 expression in pleural effusions of metastatic non-small cell lung cancer patients Cancer Research. 77: 3736-3736. DOI: 10.1158/1538-7445.Am2017-3736 |
0.325 |
|
| 2017 |
Stadanlick J, Rao A, Annunziata M, Moon E, O'brien S, Bhojnagarwala P, Feldman M, Hancock W, Conejo-Garcia J, Singhal S, Albelda S, Eruslanov E. Abstract 3707: Tumor-associated neutrophils with antigen-presenting features in early-stage human lung cancer Immunology. 77: 3707-3707. DOI: 10.1158/1538-7445.Am2017-3707 |
0.318 |
|
| 2017 |
Kraya A, Maxwell KN, Wenz BM, Wubbenhorst B, Lunceford N, Barrett A, Morrissette JJ, Feldman MD, Domchek SM, Vonderheide RH, Nathanson KL. Abstract 3691: Analysis of germline BRCA1/2 mutation associated breast and ovarian tumors reveals distinct pathways of immunosuppression Immunology. 77: 3691-3691. DOI: 10.1158/1538-7445.Am2017-3691 |
0.304 |
|
| 2016 |
Leo P, Lee G, Shih NN, Elliott R, Feldman MD, Madabhushi A. Evaluating stability of histomorphometric features across scanner and staining variations: prostate cancer diagnosis from whole slide images. Journal of Medical Imaging (Bellingham, Wash.). 3: 047502. PMID 27803941 DOI: 10.1117/1.Jmi.3.4.047502 |
0.318 |
|
| 2016 |
Santoiemma PP, Reyes C, Wang LP, McLane MW, Feldman MD, Tanyi JL, Powell DJ. Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer. Gynecologic Oncology. PMID 27470997 DOI: 10.1016/J.Ygyno.2016.07.105 |
0.344 |
|
| 2016 |
Singhal S, Bhojnagarwala PS, O'Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, Feldman MD, Hancock WW, Conejo-Garcia JR, Albelda SM, Eruslanov EB. Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer. Cancer Cell. PMID 27374224 DOI: 10.1016/J.Ccell.2016.06.001 |
0.349 |
|
| 2016 |
Posey AD, Schwab RD, Boesteanu AC, Steentoft C, Mandel U, Engels B, Stone JD, Madsen TD, Schreiber K, Haines KM, Cogdill AP, Chen TJ, Song D, Scholler J, Kranz DM, ... Feldman MD, et al. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. Immunity. 44: 1444-1454. PMID 27332733 DOI: 10.1016/J.Immuni.2016.05.014 |
0.346 |
|
| 2016 |
Yarchoan M, Ma C, Troxel AB, Stopenski SJ, Tang W, Cohen AB, Pappas-Paxinos M, Johnson BA, Chen EY, Feldman MD, Brose MS. pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer. Hormones & Cancer. PMID 26994002 DOI: 10.1007/S12672-016-0253-6 |
0.322 |
|
| 2016 |
Mansfield JR, Hoyt CC, Stack E, Feldman M, Bifulco C, Fox B. Abstract A133: Imaging in cancer immunology: Phenotyping of multiple immune cell subsets in-situ in FFPE tissue sections Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A133 |
0.378 |
|
| 2016 |
Mansfield JR, Hoyt CC, Stack E, Lin SH, Feldman M, Bifulco C, Fox BA. Abstract A08: Imaging in cancer immunology: Phenotyping of multiple immune cell subsets in-situ in FFPE tissue sections Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A08 |
0.384 |
|
| 2016 |
Eruslanov E, Bhojnagarwala P, Quatromoni J, O'Brien S, Moon E, Stephen T, Rao A, Garfall A, Hancock W, Conejo-Garcia J, Deshpande C, Feldman M, Singhal S, Albelda S. Abstract A02: The origin and role of APC-like hybrid tumor-associated neutrophils in early-stage human lung cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A02 |
0.354 |
|
| 2016 |
Clark A, O'Dwyer P, Troxel A, Lal P, Feldman M, Gallagher M, Driscoll A, Colameco C, Lewis D, Rosen M, Matro J, Bradbury A, Domchek S, Fox K, DeMichele A. Abstract P6-13-08: Palbociclib and paclitaxel on an alternating schedule for advanced breast cancer: Results of a phase Ib trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-13-08 |
0.302 |
|
| 2016 |
Soucier-Ernst D, Colameco C, Troxel A, Clark C, Shih N, Maxwell K, Morrissette J, Lieberman D, Feldman M, Goodman N, Bradbury A, Clark A, Domchek S, Fox K, Glick J, et al. Abstract P6-07-05: Mutational spectrum and tumor response in metastatic breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-07-05 |
0.347 |
|
| 2016 |
Liu M, Symmans W, Yau C, Chen Y, Rugo H, Olopade O, Datnow B, Chen B, Feldman M, Kallakury B, Hasteh F, Tickman R, Ritter J, Troxel M, Mhawech-Fauceglia P, et al. Abstract P3-07-49: Residual cancer burden (RCB) with veliparib/carboplatin in the I-SPY2 trial Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-07-49 |
0.318 |
|
| 2016 |
Ra H, Brake-Silla G, Eruslanov E, Sharp M, Deshpande C, Feldman MD, Ziober A, Wang L, Sepulveda MA, Snyder LA, Danet-Desnoyers G. Abstract PR07: Characterization of human effectors in the tumor microenvironment of NSCLC patients and lung tumor xenograft models Cancer Research. 76. DOI: 10.1158/1538-7445.Fbcr15-Pr07 |
0.324 |
|
| 2016 |
Zeigler-Johnson CM, Morales KH, Lal P, Rebbeck TR, Feldman M. Abstract 739: The role of obesity on inflammation markers in the prostate tumor microenvironment Cancer Research. 76: 739-739. DOI: 10.1158/1538-7445.Am2016-739 |
0.314 |
|
| 2016 |
Kraya AA, Maxwell KN, Wenz BM, Wubbenhorst B, DeSloover D, Lunceford N, Morrissette JD, Feldman M, Vonderheide RH, Domchek SM, Nathanson KL. Abstract 4511: Characterization of tumor neoantigen repertoire in patients with germline BRCA1/2 mutations Cancer Research. 76: 4511-4511. DOI: 10.1158/1538-7445.Am2016-4511 |
0.334 |
|
| 2016 |
Bhoj VG, Nunez-Cruz S, Zhou K, Arhontoulis D, Feldman M, Mansfield K, Peng H, Rader C, Siegel DL, Milone MC. Abstract 2295: GDNF family receptor alpha 4 (GFRa4)-targeted adoptive T-cell immunotherapy for medullary thyroid carcinoma Cancer Research. 76: 2295-2295. DOI: 10.1158/1538-7445.Am2016-2295 |
0.327 |
|
| 2015 |
Clark AS, Karasic TB, DeMichele A, Vaughn DJ, O'Hara M, Perini R, Zhang P, Lal P, Feldman M, Gallagher M, O'Dwyer PJ. Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development. Jama Oncology. 1-8. PMID 26633733 DOI: 10.1001/Jamaoncol.2015.4701 |
0.333 |
|
| 2015 |
Banerjee S, Wei Z, Tan F, Peck KN, Shih N, Feldman M, Rebbeck TR, Alwine JC, Robertson ES. Distinct microbiological signatures associated with triple negative breast cancer. Scientific Reports. 5: 15162. PMID 26469225 DOI: 10.1038/Srep15162 |
0.35 |
|
| 2015 |
Datta J, Rosemblit C, Berk E, Showalter L, Namjoshi P, Mick R, Lee KP, Brod AM, Yang RL, Kelz RR, Fitzpatrick E, Hoyt C, Feldman MD, Zhang PJ, Xu S, et al. Progressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restoration. Oncoimmunology. 4: e1022301. PMID 26451293 DOI: 10.1080/2162402X.2015.1022301 |
0.303 |
|
| 2015 |
Litjens GJ, Elliott R, Shih NN, Feldman MD, Kobus T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ, Madabhushi A. Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging. Radiology. 142856. PMID 26192734 DOI: 10.1148/Radiol.2015142856 |
0.312 |
|
| 2015 |
Singanamalli A, Rusu M, Sparks RE, Shih NN, Ziober A, Wang LP, Tomaszewski J, Rosen M, Feldman M, Madabhushi A. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer. Journal of Magnetic Resonance Imaging : Jmri. PMID 26110513 DOI: 10.1002/Jmri.24975 |
0.304 |
|
| 2015 |
Chung SH, Feldman MD, Martinez D, Kim H, Putt ME, Busch DR, Tchou J, Czerniecki BJ, Schnall MD, Rosen MA, DeMichele A, Yodh AG, Choe R. Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures. Breast Cancer Research : Bcr. 17: 72. PMID 26013572 DOI: 10.1186/S13058-015-0578-Z |
0.356 |
|
| 2015 |
Dey S, Sayers CM, Verginadis II, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA, Koumenis C. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. The Journal of Clinical Investigation. 125: 2592-608. PMID 26011642 DOI: 10.1172/Jci78031 |
0.322 |
|
| 2015 |
Wang E, Wang LC, Tsai CY, Bhoj V, Gershenson Z, Moon E, Newick K, Sun J, Lo A, Baradet T, Feldman MD, Barrett D, Puré E, Albelda S, Milone MC. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunology Research. 3: 815-26. PMID 25941351 DOI: 10.1158/2326-6066.Cir-15-0054 |
0.308 |
|
| 2015 |
Mahrooghy M, Ashraf A, Days D, Mcdonald E, Rosen M, Mies C, Feldman M, Kontos D. Pharmacokinetic Tumor Heterogeneity as a Prognostic Biomarker for Classifying Breast Cancer Recurrence Risk. Ieee Transactions On Bio-Medical Engineering. PMID 25622311 DOI: 10.1109/Tbme.2015.2395812 |
0.358 |
|
| 2015 |
Lee G, Singanamalli A, Wang H, Feldman MD, Master SR, Shih NN, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer. Ieee Transactions On Medical Imaging. 34: 284-97. PMID 25203987 DOI: 10.1109/Tmi.2014.2355175 |
0.328 |
|
| 2015 |
Eruslanov E, Bhojnagarwala P, Quatromoni J, Stephen T, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock W, Conejo-Garcia J, Feldman M, Singhal S, Albelda S. Abstract A66: Tumor-associated neutrophils in early stage human lung cancer are not immunosuppressive, but exhibit an inflammatory phenotype and provide accessory signals for T cell activation Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A66 |
0.364 |
|
| 2015 |
Rech AJ, Twyman C, Maity A, Rengan R, Pauken KE, Stelekati E, Xu B, Dada H, Odorizzi PM, Herati RD, Mansfield KD, Patsch D, Amaravadi R, Schuchter L, Ishwaran H, ... ... Feldman M, et al. Abstract A52: Radiation and dual PD-L1 and CTLA4 checkpoint blockade non-redundantly improves tumor resistance, response, and immunity Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A52 |
0.332 |
|
| 2015 |
DeMichele AM, Colameco CB, Kalota A, Troxel AB, Holmes R, Cimildoro R, Zafman K, Fox KR, Domchek SM, Gogineni K, Bradbury AR, Matro JM, Shih N, Feldman MD, Clark AS, et al. Abstract CT114: A phase II trial of exemestane and ruxolitinib for aI-resistant ER+ breast cancer: Interim safety, efficacy, and biomarker analysis Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct114 |
0.348 |
|
| 2015 |
Maxwell KN, Soucier-Ernst DJ, Carpenter EL, Troxel AB, Colameco C, Clark C, Feldman MD, Kakrecha B, Langer M, Lee J, Lewis DA, Lieberman D, Morrissette J, Pan T, Yee SS, et al. Abstract 618: Comparison of mutational spectra in metastatic tumors and cell-free DNA in breast cancer patients Cancer Research. 75: 618-618. DOI: 10.1158/1538-7445.Am2015-618 |
0.374 |
|
| 2015 |
Lal P, Yamoah K, Ziober A, Walker A, Zhou W, Spangler E, Zeigler-Johnson C, Feldman M, Rebbeck TR. Abstract 4608: Racial differences in the distribution of prostate tumor biomarkers and treatment failure: The SCORE study Cancer Research. 75: 4608-4608. DOI: 10.1158/1538-7445.Am2015-4608 |
0.328 |
|
| 2015 |
Maxwell KN, Sloover DD, Wubbenhorst B, Wenz B, Lunceford N, Emery L, D'Andrea K, Daber RD, Feldman MD, Domchek SM, Nathanson KL. Abstract 2990: Evidence for diverse mechanisms of tumorigenesis in breast and ovarian tumors of BRCA1/2 carriers Cancer Research. 75: 2990-2990. DOI: 10.1158/1538-7445.Am2015-2990 |
0.344 |
|
| 2015 |
Rech AJ, Victor CT, Maity A, Rengan R, Pauken KE, Stelekati E, Benci J, Xu B, Dada H, Odorizzi PM, Herati RS, Mansfield KD, Patsch D, Amaravadi RK, Schuchter LM, ... ... Feldman MD, et al. Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity Cancer Research. 75: 2858-2858. DOI: 10.1158/1538-7445.Am2015-2858 |
0.341 |
|
| 2015 |
Dey S, Sayers CM, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJL, Fuchs SY, Diehl JA, Koumenis C. Abstract 1262: The transcription factor ATF4 regulates resistance to anoikis and promotes metastasis in fibrosarcoma via cooperative upregulation of Heme Oxygenase-1 with Nrf2 Cancer Research. 75: 1262-1262. DOI: 10.1158/1538-7445.Am2015-1262 |
0.331 |
|
| 2014 |
Litjens GJ, Huisman HJ, Elliott RM, Shih NN, Feldman MD, Viswanath S, Fütterer JJ, Bomers JG, Madabhushi A. Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy. Journal of Medical Imaging (Bellingham, Wash.). 1: 035001. PMID 26158070 DOI: 10.1117/1.Jmi.1.3.035001 |
0.309 |
|
| 2014 |
Wang H, Cruz-Roa A, Basavanhally A, Gilmore H, Shih N, Feldman M, Tomaszewski J, Gonzalez F, Madabhushi A. Mitosis detection in breast cancer pathology images by combining handcrafted and convolutional neural network features. Journal of Medical Imaging (Bellingham, Wash.). 1: 034003. PMID 26158062 DOI: 10.1117/1.Jmi.1.3.034003 |
0.306 |
|
| 2014 |
Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW, Conejo-Garcia JR, Feldman M, Albelda SM, Singhal S. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. The Journal of Clinical Investigation. 124: 5466-80. PMID 25384214 DOI: 10.1172/Jci77053 |
0.338 |
|
| 2014 |
Baldwin DA, Feldman M, Alwine JC, Robertson ES. Metagenomic assay for identification of microbial pathogens in tumor tissues. Mbio. 5: e01714-14. PMID 25227467 DOI: 10.1128/Mbio.01714-14 |
0.321 |
|
| 2014 |
Choe R, Putt ME, Carlile PM, Durduran T, Giammarco JM, Busch DR, Jung KW, Czerniecki BJ, Tchou J, Feldman MD, Mies C, Rosen MA, Schnall MD, DeMichele A, Yodh AG. Optically measured microvascular blood flow contrast of malignant breast tumors. Plos One. 9: e99683. PMID 24967878 DOI: 10.1371/Journal.Pone.0099683 |
0.338 |
|
| 2014 |
Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. Plos One. 9: e97954. PMID 24875018 DOI: 10.1371/Journal.Pone.0097954 |
0.336 |
|
| 2014 |
Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. 20: 607-15. PMID 24793239 DOI: 10.1038/Nm.3541 |
0.315 |
|
| 2014 |
Ashraf AB, Daye D, Gavenonis S, Mies C, Feldman M, Rosen M, Kontos D. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Radiology. 272: 374-84. PMID 24702725 DOI: 10.1148/Radiol.14131375 |
0.359 |
|
| 2014 |
Agner SC, Rosen MA, Englander S, Tomaszewski JE, Feldman MD, Zhang P, Mies C, Schnall MD, Madabhushi A. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. Radiology. 272: 91-9. PMID 24620909 DOI: 10.1148/Radiol.14121031 |
0.333 |
|
| 2014 |
Padmanabhan RK, Somasundar VH, Griffith SD, Zhu J, Samoyedny D, Tan KS, Hu J, Liao X, Carin L, Yoon SS, Flaherty KT, Dipaola RS, Heitjan DF, Lal P, Feldman MD, et al. An active learning approach for rapid characterization of endothelial cells in human tumors. Plos One. 9: e90495. PMID 24603893 DOI: 10.1371/Journal.Pone.0090495 |
0.343 |
|
| 2014 |
Yarchoan M, Cohen AB, Stopenski SJ, Haddad CA, Scott NL, Ma C, Ransom ER, Troxel AB, Feldman MD, Brose MS. Molecular predictors of response to sorafenib in patients with radioactive iodine-resistant advanced thyroid cancer. Journal of Clinical Oncology. 32: 6088-6088. DOI: 10.1200/Jco.2014.32.15_Suppl.6088 |
0.372 |
|
| 2014 |
Clark AS, O'Dwyer PJ, Heitjan D, Lal P, Feldman MD, Gallagher M, Redlinger C, Colameco C, Lewis D, Zafman K, Langer M, Rosen MA, Gogineni K, Bradbury AR, Domchek SM, et al. A phase I trial of palbociclib and paclitaxel in metastatic breast cancer. Journal of Clinical Oncology. 32: 527-527. DOI: 10.1200/Jco.2014.32.15_Suppl.527 |
0.311 |
|
| 2014 |
Cruz-Roa A, Basavanhally A, González F, Gilmore H, Feldman M, Ganesan S, Shih N, Tomaszewski J, Madabhushi A. Automatic detection of invasive ductal carcinoma in whole slide images with convolutional neural networks Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9041. DOI: 10.1117/12.2043872 |
0.338 |
|
| 2014 |
Litjens G, Huisman H, Elliott R, Shih N, Feldman M, Viswanath S, Fütterer J, Bomers J, Madabhushi A. Distinguishing benign confounding treatment changes from residual prostate cancer on MRI following laser ablation Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9036. DOI: 10.1117/12.2043819 |
0.328 |
|
| 2014 |
Singanamalli A, Wang H, Lee G, Shih N, Rosen M, Master S, Tomaszewski J, Feldman M, Madabhushi A. Supervised multi-view canonical correlation analysis: Fused multimodal prediction of disease diagnosis and prognosis Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9038. DOI: 10.1117/12.2043762 |
0.32 |
|
| 2014 |
Litjens GJS, Elliott R, Shih N, Feldman M, Barentsz JO, Van De Kaa CAH, Kovacs I, Huisman HJ, Madabhushi A. Distinguishing prostate cancer from benign confounders via a cascaded classifier on multi-parametric MRI Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9035. DOI: 10.1117/12.2043751 |
0.328 |
|
| 2013 |
Basavanhally A, Ganesan S, Feldman M, Shih N, Mies C, Tomaszewski J, Madabhushi A. Multi-field-of-view framework for distinguishing tumor grade in ER+ breast cancer from entire histopathology slides. Ieee Transactions On Bio-Medical Engineering. 60: 2089-99. PMID 23392336 DOI: 10.1109/Tbme.2013.2245129 |
0.357 |
|
| 2013 |
Busch DR, Choe R, Rosen MA, Guo W, Durduran T, Feldman MD, Mies C, Czerniecki BJ, Tchou J, Demichele A, Schnall MD, Yodh AG. Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy. Biomedical Optics Express. 4: 105-21. PMID 23304651 DOI: 10.1364/Boe.4.000105 |
0.334 |
|
| 2013 |
DeMichele A, Clark AS, Heitjan D, Randolph S, Gallagher M, Lal P, Feldman MD, Zhang PJ, Schnader A, Zafman K, Domchek SM, Gogineni K, Keefe SM, Fox KR, O'Dwyer PJ. A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer. Journal of Clinical Oncology. 31: 519-519. DOI: 10.1200/Jco.2013.31.15_Suppl.519 |
0.313 |
|
| 2013 |
Maxwell KN, De Sloover D, Emery L, Wubbenhorst B, D'Andrea KP, Long J, Mueller R, Powers J, Stopfer J, Feldman MD, Domchek SM, Daber R, Nathanson KL. The mutational spectrum of breast and ovarian tumors from BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology. 31: 1510-1510. DOI: 10.1200/Jco.2013.31.15_Suppl.1510 |
0.301 |
|
| 2013 |
Wang C, King R, Feldman M, Hoyt C. Multiplexed characterization of cancer immune response in FFPE biopsies - initial performance of a new approach Journal For Immunotherapy of Cancer. 1: P54. DOI: 10.1186/2051-1426-1-S1-P54 |
0.375 |
|
| 2013 |
Garg R, Lal P, Blando J, Benavides FJ, Feldman MD, Smyth EM, Kazanietz MG. Abstract LB-154: COX-2 as a mediator of oncogenic PKCε in prostate cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-154 |
0.315 |
|
| 2013 |
Zsiros E, Lee H, Hagemann IS, Duttagupta P, Frank R, Garrabrant T, Levine BL, June CH, Tanyi J, Kandalaft L, Feldman M, Coukos G. Abstract 3968: Ovarian cancer chemokine microenvironment is conducive to homing of CD3/CD28 co-stimulated T cells prepared for adoptive transfer therapy. Cancer Research. 73: 3968-3968. DOI: 10.1158/1538-7445.Am2013-3968 |
0.339 |
|
| 2013 |
Madabhushi A, Doyle S, Basavanhally A, Gilmore H, Harris L, Shih N, Mies C, Feldman M, Tomaszewski J, Ganesan S. Abstract P4-03-04: Computer extracted image measurements of nuclear shape and texture from H&E images appear to stratify low and high risk ER+ breast cancers assessed via oncotype DX Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-03-04 |
0.314 |
|
| 2013 |
Clark A, Lal P, Tan K, Heitjan D, Feldman M, Zhang P, Gallagher M, Domchek S, Gogineni K, Keefe S, Fox K, O'Dwyer P, DeMichele A. Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-16-20 |
0.36 |
|
| 2013 |
Mahrooghy M, Ashraf A, Gavenonis S, Daye D, Mies C, Feldman M, Rosen M, Kontos D. Abstract P2-02-04: Kinetic heterogeneity features on breast DCE-MRI as prognostic markers of breast cancer recurrence Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-02-04 |
0.369 |
|
| 2013 |
Singanamalli A, Sparks R, Rusu M, Shih N, Ziober A, Tomaszewski J, Rosen M, Feldman M, Madabhushi A. Identifying in vivo DCE MRI parameters correlated with ex vivo quantitative microvessel architecture: A radiohistomorphometric approach Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8676. DOI: 10.1117/12.2008136 |
0.338 |
|
| 2012 |
Doyle S, Feldman MD, Shih N, Tomaszewski J, Madabhushi A. Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. Bmc Bioinformatics. 13: 282. PMID 23110677 DOI: 10.1186/1471-2105-13-282 |
0.309 |
|
| 2012 |
Surrey LF, Thaker AA, Zhang PJ, Karakousis G, Feldman MD. Ectopic functioning adrenocortical oncocytic adenoma (oncocytoma) with myelolipoma causing virilization. Case Reports in Pathology. 2012: 326418. PMID 23094172 DOI: 10.1155/2012/326418 |
0.303 |
|
| 2012 |
Hipp J, Monaco J, Kunju LP, Cheng J, Yagi Y, Rodriguez-Canales J, Emmert-Buck MR, Hewitt S, Feldman MD, Tomaszewski JE, Toner M, Tompkins RG, Flotte T, Lucas D, Gilbertson JR, et al. Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification. Analytical Cellular Pathology (Amsterdam). 35: 251-65. PMID 22425661 DOI: 10.3233/Acp-2012-0054 |
0.314 |
|
| 2012 |
Janowczyk A, Chandran S, Singh R, Sasaroli D, Coukos G, Feldman MD, Madabhushi A. High-throughput biomarker segmentation on ovarian cancer tissue microarrays via hierarchical normalized cuts. Ieee Transactions On Bio-Medical Engineering. 59: 1240-52. PMID 22180503 DOI: 10.1109/Tbme.2011.2179546 |
0.315 |
|
| 2012 |
Doyle S, Feldman M, Tomaszewski J, Madabhushi A. A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies. Ieee Transactions On Bio-Medical Engineering. 59: 1205-18. PMID 20570758 DOI: 10.1109/Tbme.2010.2053540 |
0.321 |
|
| 2011 |
Hoyt CC, Hagemann IS, Hagemann AR, Wang L, Hung E, Lane K, Coukos G, Feldman MD. Performance characteristics and validation of automated tumor-infiltrating lymphocyte counting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10562. PMID 28021887 DOI: 10.1200/Jco.2011.29.15_Suppl.10562 |
0.346 |
|
| 2011 |
Basavanhally A, Feldman M, Shih N, Mies C, Tomaszewski J, Ganesan S, Madabhushi A. Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. Journal of Pathology Informatics. 2: S1. PMID 22811953 DOI: 10.4103/2153-3539.92027 |
0.336 |
|
| 2011 |
Golugula A, Lee G, Master SR, Feldman MD, Tomaszewski JE, Speicher DW, Madabhushi A. Supervised regularized canonical correlation analysis: integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery. Bmc Bioinformatics. 12: 483. PMID 22182303 DOI: 10.1186/1471-2105-12-483 |
0.308 |
|
| 2011 |
Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ, Feldman MD, Coukos G. Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biology & Therapy. 12: 367-77. PMID 21785280 DOI: 10.4161/Cbt.12.4.16908 |
0.357 |
|
| 2011 |
Al-Kofahi Y, Lassoued W, Grama K, Nath SK, Zhu J, Oueslati R, Feldman M, Lee WM, Roysam B. Cell-based quantification of molecular biomarkers in histopathology specimens. Histopathology. 59: 40-54. PMID 21771025 DOI: 10.1111/J.1365-2559.2011.03878.X |
0.326 |
|
| 2011 |
Reddy NP, Miyamoto S, Araki K, Liu T, Feldman M, O'Malley BW, Li D. A novel orthotopic mouse model of head and neck cancer with molecular imaging. The Laryngoscope. 121: 1202-7. PMID 21480280 DOI: 10.1002/Lary.21794 |
0.345 |
|
| 2011 |
Xiao G, Bloch BN, Chappelow J, Genega EM, Rofsky NM, Lenkinski RE, Tomaszewski J, Feldman MD, Rosen M, Madabhushi A. Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer. Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society. 35: 568-78. PMID 21255974 DOI: 10.1016/J.Compmedimag.2010.12.003 |
0.312 |
|
| 2011 |
Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA. Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. Breast Cancer Research and Treatment. 129: 361-72. PMID 20976540 DOI: 10.1007/S10549-010-1227-Y |
0.326 |
|
| 2011 |
Rhee SS, Lim B, Kim H, Wang Y, Aziz U, Butt U, Tang W, Vuchak LA, DeMichele A, Troxel AB, Feldman MD, Meinkoth JL, Brose MS. Abstract 3840: Rap1 GTPase activating protein (Rap1GAP) is downregulated in DCIS and invasive ductal carcinoma Cancer Research. 71: 3840-3840. DOI: 10.1158/1538-7445.Am2011-3840 |
0.34 |
|
| 2011 |
Chung S, Feldman M, Choe R, Martinez D, Yodh A. P2-10-03: Non-Invasive In Vivo Characterization of Cancer-Cell Proliferation & Angiogenesis in Cancer-Cell-Surrounding Stromal Microenvironment In-Vivo Using Diffuse Optical Tomography. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-10-03 |
0.363 |
|
| 2011 |
DeMichele A, Clark A, Randolph S, Christensen J, Gallagher M, Lal P, Feldman M, Zhang P, Perini R, Velders L, Domchek S, Kaplan-Tweed C, Gogineni K, Keefe S, Fox K, et al. P1-17-06: A Phase II Trial of the CDK 4/6 Inhibitor PD0332991 in Women with Advanced Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-17-06 |
0.339 |
|
| 2011 |
Basavanhally A, Yu E, Xu J, Ganesan S, Feldman M, Tomaszewski J, Madabhushi A. Incorporating domain knowledge for tubule detection in breast histopathology using O'Callaghan neighborhoods Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7963. DOI: 10.1117/12.878092 |
0.307 |
|
| 2010 |
Monaco JP, Tomaszewski JE, Feldman MD, Hagemann I, Moradi M, Mousavi P, Boag A, Davidson C, Abolmaesumi P, Madabhushi A. High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models. Medical Image Analysis. 14: 617-29. PMID 20493759 DOI: 10.1016/J.Media.2010.04.007 |
0.312 |
|
| 2010 |
Madabhushi A, Doyle S, Lee G, Basavanhally A, Monaco J, Masters S, Tomaszewski J, Feldman M. Integrated diagnostics: a conceptual framework with examples. Clinical Chemistry and Laboratory Medicine. 48: 989-98. PMID 20491597 DOI: 10.1515/Cclm.2010.193 |
0.302 |
|
| 2010 |
Tsygankova OM, Ma C, Tang W, Korch C, Feldman MD, Lv Y, Brose MS, Meinkoth JL. Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Molecular and Cellular Biology. 30: 3262-74. PMID 20439492 DOI: 10.1128/Mcb.01345-09 |
0.3 |
|
| 2010 |
Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KK, Welm AL, Feldman MD, Weber BL, Weaver VM. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. The Journal of Clinical Investigation. 120: 1535-50. PMID 20389018 DOI: 10.1172/Jci39534 |
0.353 |
|
| 2010 |
Fatakdawala H, Xu J, Basavanhally A, Bhanot G, Ganesan S, Feldman M, Tomaszewski JE, Madabhushi A. Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. Ieee Transactions On Bio-Medical Engineering. 57: 1676-89. PMID 20172780 DOI: 10.1109/Tbme.2010.2041232 |
0.349 |
|
| 2010 |
Basavanhally AN, Ganesan S, Agner S, Monaco JP, Feldman MD, Tomaszewski JE, Bhanot G, Madabhushi A. Computerized image-based detection and grading of lymphocytic infiltration in HER2+ breast cancer histopathology. Ieee Transactions On Bio-Medical Engineering. 57: 642-53. PMID 19884074 DOI: 10.1109/Tbme.2009.2035305 |
0.341 |
|
| 2010 |
Hoyt C, Lane K, Gardner H, Feldman M. Abstract 1141: Quantitating signaling pathway proteins in FFPE sections using multispectral imaging and automated image analysis Cancer Research. 70: 1141-1141. DOI: 10.1158/1538-7445.Am10-1141 |
0.326 |
|
| 2010 |
Ransom ER, Leibowitz JM, Ma C, Puttaswamy K, Troxel A, Lee W, Feldman M, Brose MS. Quantified immunohistochemistry demonstrates cellular level targets of an oral multikinase inhibitor in metastatic thyroid cancer Laryngoscope. 120. DOI: 10.1002/Lary.21231 |
0.329 |
|
| 2009 |
Lan K, Murakami M, Bajaj B, Kaul R, He Z, Gan R, Feldman M, Robertson ES. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Cancer Biology & Therapy. 8: 2136-43. PMID 19783901 DOI: 10.4161/Cbt.8.22.9743 |
0.308 |
|
| 2009 |
Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, ... Feldman MD, et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biology & Therapy. 8: 907-16. PMID 19276661 DOI: 10.4161/Cbt.8.10.8132 |
0.33 |
|
| 2009 |
Furstenau DK, Mitra N, Wan F, Lewis R, Feldman MD, Fraker DL, Guvakova MA. Abstract A45: Upregulation of the small GTPase Rap1 and the insulin‐like growth factor I receptor in breast epithelium occurs in carcinoma in situ Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A45 |
0.34 |
|
| 2009 |
Naik J, Doyle S, Basavanally A, Ganesan S, Feldman MD, Tomaszewski JE, Madabhushi A. A boosted distance metric: Application to content based image retrieval and classification of digitized histopathology Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7260. DOI: 10.1117/12.813931 |
0.327 |
|
| 2008 |
Nellore A, Paziana K, Tsgankova OM, Wang Y, Lv Y, Puttaswamy K, Troxel AB, Feldman MD, Meinkoth JL, Brose MS. Progressive loss of Rap1GAP in benign and invasive thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6059. PMID 27950576 DOI: 10.1200/Jco.2008.26.15_Suppl.6059 |
0.334 |
|
| 2008 |
O'Donnell RK, Feldman M, Mick R, Muschel RJ. Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 56: 803-10. PMID 18505934 DOI: 10.1369/Jhc.2008.950790 |
0.301 |
|
| 2008 |
Xu X, Gimotty PA, Guerry D, Karakousis G, Van Belle P, Liang H, Montone K, Pasha T, Ming ME, Acs G, Feldman M, Barth S, Hammond R, Elenitsas R, Zhang PJ, et al. Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Human Pathology. 39: 901-9. PMID 18440591 DOI: 10.1016/J.Humpath.2007.10.017 |
0.349 |
|
| 2008 |
Selvakumaran M, Yao KS, Feldman MD, O'Dwyer PJ. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Biochemical Pharmacology. 75: 627-38. PMID 18178171 DOI: 10.1016/J.Bcp.2007.09.029 |
0.309 |
|
| 2007 |
Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH. Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. Cancer Research. 67: 10546-55. PMID 17974999 DOI: 10.1158/0008-5472.Can-07-2765 |
0.352 |
|
| 2007 |
Zhan Y, Ou Y, Feldman M, Tomaszeweski J, Davatzikos C, Shen D. Registering histologic and MR images of prostate for image-based cancer detection. Academic Radiology. 14: 1367-81. PMID 17964460 DOI: 10.1016/J.Acra.2007.07.018 |
0.32 |
|
| 2007 |
Quraishi I, Rishi M, Feldman M, Wargovich MJ, Weber B. Clinical validation of breast cancer biomarkers using tissue microarray technology. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 45-9. PMID 17536306 DOI: 10.1097/01.Pai.0000213129.86288.34 |
0.347 |
|
| 2006 |
Murphy DA, Makonnen S, Lassoued W, Feldman MD, Carter C, Lee WM. Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006). The American Journal of Pathology. 169: 1875-85. PMID 17071608 DOI: 10.2353/Ajpath.2006.050711 |
0.307 |
|
| 2006 |
Menon C, Ghartey A, Canter R, Feldman M, Fraker DL. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin. Annals of Surgery. 244: 781-791. PMID 17060772 DOI: 10.1097/01.Sla.0000231723.81218.72 |
0.322 |
|
| 2006 |
Harris EE, Hwang WT, Lee EA, Cengel KA, Feldman MD, Demichele A, Kao G, Solin LJ. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. The Breast Journal. 12: 431-6. PMID 16958961 DOI: 10.1111/J.1075-122X.2006.00297.X |
0.316 |
|
| 2005 |
Domchek SM, Fox KR, Recio A, Schuchter LM, Davidson R, Demichele A, Feldman MD, Vonderheide RH. Telomerase vaccination of metastatic breast cancer patients induces antigen-specific tumor infiltrating lymphocytes and tumor necrosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2505. PMID 27945956 DOI: 10.1200/Jco.2005.23.16_Suppl.2505 |
0.376 |
|
| 2005 |
Madabhushi A, Feldman MD, Metaxas DN, Tomaszeweski J, Chute D. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI. Ieee Transactions On Medical Imaging. 24: 1611-25. PMID 16350920 DOI: 10.1109/Tmi.2005.859208 |
0.322 |
|
| 2005 |
Wood AK, Ansaloni S, Ziemer LS, Lee WM, Feldman MD, Sehgal CM. The antivascular action of physiotherapy ultrasound on murine tumors. Ultrasound in Medicine & Biology. 31: 1403-10. PMID 16223644 DOI: 10.1016/J.Ultrasmedbio.2005.06.008 |
0.317 |
|
| 1999 |
El-Shami KM, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines Journal of Interferon and Cytokine Research. 19: 1391-1401. PMID 10638708 DOI: 10.1089/107999099312858 |
0.302 |
|
| 1985 |
Eisenbach L, Segal S, Feldman M. Proteolytic Enzymes in tumor metastasis. I. Plasminogen activator in clones of lewis lung carcinoma and t10 sarcoma1, 2 Journal of the National Cancer Institute. 74: 77-85. PMID 3855489 DOI: 10.1093/Jnci/74.1.77 |
0.332 |
|
| 1985 |
Eisenbach L, Feldman M. Genes and antigens controlling tumor metastases Hamatologie Und Bluttransfusion. 29: 499-507. PMID 2411643 DOI: 10.1007/978-3-642-70385-0_101 |
0.337 |
|
| 1979 |
Fogel M, Gorelik E, Segal S, Feldman M. Differences in Cell Surface Antigens of Tumor Metastases and Those of the Local Tumor Journal of the National Cancer Institute. 62: 585-588. PMID 84091 DOI: 10.1093/Jnci/62.3.585 |
0.309 |
|
| Show low-probability matches. |